Drug Development for Hidradenitis Suppurativa & Rare Diseases, a Regulatory Perspective

Time: 9:00 am
day: Day Two

Details:

  •  Demonstrating efficacy for the treatment of Hidradenitis Suppurativa
  • Exploring the development of endpoints that are fit-for-purpose
  • Incorporating patient perspectives
  • Analyzing evidentiary standards for rare diseases
  • Examining potential development strategies

Speakers: